Reuters logo
BRIEF-Cellectar Biosciences announces new preclinical data
October 30, 2017 / 12:52 PM / in a month

BRIEF-Cellectar Biosciences announces new preclinical data

Oct 30 (Reuters) - Cellectar Biosciences Inc

* ‍New preclinical data suggest that Cellectar Biosciences’ PDC platform provides enhanced outcomes in combination with external radiation​

* Cellectar Biosciences Inc - ‍investigators observed that CLR 127 was taken up and retained in tumor cells at 6-10 fold higher level than normal tissue​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below